EGF receptor (ERBB1) abundance in adipose tissue is reduced in insulin-resistant and type 2 diabetic women

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages

  Rogers, Carlyle ^a   Moukdar, Fatiha ^a   McGee, Marie A ^a   Davis, Barbara ^a   Buehrer, Benjamin M ^c   Daniel, Kiefer W ^c   Collins, Sheila ^d   Barakat, Hisham ^a,b   Robidoux, Jacques ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Zen Bio Inc   (United States)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FATTY ACID BINDING PROTEIN 4; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LIPOPROTEIN LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL LIPASE;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; BODY MASS INDEX; CELLS, CULTURED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MIDDLE AGED; PHOSPHORYLATION; PPAR GAMMA; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84858050103     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1033     Document Type: Article

References (48)

1. Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, Haas S, Nigam SC, Schuette R 2010 Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity Electronic Medical Record database. Popul Health Manag 13:151-161
2. McLaughlin T, Abbasi F, Lamendola C, Reaven G 2007 Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 167:642-648 (Pubitemid 46598455)
3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW 2003 Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808 (Pubitemid 38063703)
4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H 2003 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830 (Pubitemid 38063705)
5. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52:1779-1785 (Pubitemid 36792470)
6. Danforth Jr E 2000 Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13
7. Ravussin E, Smith SR 2002 Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann NY Acad Sci 967:363-378 (Pubitemid 34721922)
8. Virtue S, Vidal-Puig A 2010 Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 1801:338-349
9. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Näslund E, Britton T, Concha H, Hassan M, Rydén M, Frisén J, Arner P 2008 Dynamics of fat cell turnover in humans. Nature 453:783-787 (Pubitemid 351793777)
10. Björntorp P 1974 Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 23:1091-1102
11. Skurk T, Alberti-Huber C, Herder C, Hauner H 2007 Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023-1033 (Pubitemid 46465679)
12. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE 2000 Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 43:1498-1506 (Pubitemid 32734855)
13. Lönn M, Mehlig K, Bengtsson C, Lissner L 2010 Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J 24:326-331
14. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, Lamendola C, Reaven GM, Cushman SW 2007 Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50:1707-1715 (Pubitemid 47036653)
15. Yarden Y, Sliwkowski MX 2001 Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127-137 (Pubitemid 33674041)
16. Harris RC, Chung E, Coffey RJ 2003EGFreceptor ligands. Exp Cell Res 284:2-13
17. Serrero G 1987 EGF inhibits the differentiation of adipocyte precursors in primary cultures. Biochem Biophys Res Commun 146: 194-202 (Pubitemid 17102982)
18. Adachi H, Kurachi H, Homma H, Adachi K, Imai T, Morishige K, Matsuzawa Y, Miyake A 1994 Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro. Endocrinology 135:1824-1830 (Pubitemid 24363872)
19. Bachmeier M, Löffler G 1995 Influence of growth factors on growth and differentiation of 3T3-L1 preadipocytes in serum-free conditions. Eur J Cell Biol 68:323-329
20. Harrington M, Pond-Tor S, Boney CM 2007 Role of epidermal growth factor and ErbB2 receptors in 3T3-L1 adipogenesis. Obesity (Silver Spring) 15:563-571 (Pubitemid 46643308)
21. Lee JS, Suh JM, Park HG, Bak EJ, Yoo YJ, Cha JH 2008 Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages. Differentiation 76:478-487 (Pubitemid 351725838)
22. Li F, Wang D, Zhou Y, Zhou B, Yang Y, Chen H, Song J 2008 Protein kinase A suppresses the differentiation of 3T3-L1 preadipocytes. Cell Res 18:311-323 (Pubitemid 351206167)
23. Pagano E, Coso O, Calvo JC 2008 Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes. J Cell Biochem 104:274-285
24. Hauner H, Röhrig K, Petruschke T 1995 Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur J Clin Invest 25:90-96
25. Hebert TL, Wu X, Yu G, Goh BC, Halvorsen YD, Wang Z, Moro C, Gimble JM 2009 Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis. J Tissue Eng Regen Med 3:553-561
26. Koutsari C, Jensen MD 2006 Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity. J Lipid Res 47:1643-1650
27. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R 2003 Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26:3320-3325 (Pubitemid 37466894)
28. Grünwald V, Hidalgo M 2003 Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst 95:851-867 (Pubitemid 36833877)
29. Bays H, Abate N, Chandalia M 2005 Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol 1:39-59
30. McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, Ruge T, Gilbert M, Fielding BA, Frayn KN, Karpe F 2011 Downregulation of adipose tissue fatty acid trafficking in obesity. Diabetes 60:47-55
31. Koellensperger E, von Heimburg D, Markowicz M, Pallua N 2006 Human serum from platelet-poor plasma for the culture of primary human preadipocytes. Stem Cells 24:1218-1225 (Pubitemid 44464690)
32. Skurk T, Ecklebe S, Hauner H 2007 A novel technique to propagate primary human preadipocytes without loss of differentiation capacity. Obesity (Silver Spring) 15:2925-2931 (Pubitemid 351256653)
33. Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E 2006 Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity 14:1543-1552 (Pubitemid 46214821)
34. MacLaren R, Cui W, Simard S, Cianflone K 2008 Influence of obesity and insulin sensitivity on insulin signaling genes inhumanomental and subcutaneous adipose tissue. J Lipid Res 49:308-323 (Pubitemid 351213615)
35. Montague CT, Prins JB, Sanders L, Zhang J, Sewter CP, Digby J, Byrne CD, O'Rahilly S 1998 Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384-1391 (Pubitemid 28396940)
36. Ellis JM, Li LO, Wu PC, Koves TR, Ilkayeva O, Stevens RD, Watkins SM, Muoio DM, Coleman RA 2010 Adipose acyl-CoA synthetase-1 directs fatty acids toward β-oxidation and is required for cold thermogenesis. Cell Metab 12:53-64
37. Lobo S, Wiczer BM, Bernlohr DA 2009 Functional analysis of longchain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. J Biol Chem 284:18347-18356
38. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116:1784-1792 (Pubitemid 44033298)
39. Shetty S, Kusminski CM, Scherer PE 2009 Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci 30:234-239
40. Liu M, Liu F 2010 Transcriptional and post-translational regulation of adiponectin. Biochem J 425:41-52
41. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB, Holm C, Arner P, Blaak EE 2007 Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocrinol Metab 92:2292-2299 (Pubitemid 46997136)
42. Hou XG, Moser S, Sarr MG, Thompson GB, Que FG, Jensen MD 2009 Visceral and subcutaneous adipose tissue diacylglycerol acyltransferase activity in humans. Obesity (Silver Spring) 17:1129-1134
43. Ranganathan G, Unal R, Pokrovskaya I, Yao-Borengasser A, Phanavanh B, Lecka-Czernik B, Rasouli N, Kern PA 2006 The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47: 2444-2450 (Pubitemid 44936106)
44. Bogacka I, Xie H, Bray GA, Smith SR 2004 The effect of pioglitazone on peroxisome proliferator-activated receptor-γ target genes related to lipid storage in vivo. Diabetes Care 27:1660-1667 (Pubitemid 38857441)
45. Björntorp P, Karlsson M, Pertoft H, Pettersson P, SjöströmL, Smith U1978 Isolation and characterization of cells from rat adipose tissue developing into adipocytes. J Lipid Res 19:316-324
46. Wang H, Eckel RH 2009 Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab 297:E271-E288
47. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita S, Matsuzawa Y 1999 CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19:1333-1339 (Pubitemid 29227655)
48. Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS 2008 Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest 118:2640-2650 (Pubitemid 351949791)